---
figid: PMC4521372__13075_2015_708_Fig6_HTML
figlink: /pmc/articles/PMC4521372/figure/Fig6/
number: F6
caption: Schematic hypothesis about interleukin (IL)-13 synthesis induced through
  Smad and mitogen-activated protein kinase (MAPK) pathways in response to transforming
  growth factor (TGF)-β in T cells of patients with systemic sclerosis. TGF-β binds
  first to its type II receptor (TβRII), which then recruits and phosphorylates the
  type I receptor (TβRI), leading to activin receptor-like kinase (ALK5) activation
  within the receptor complex. The TβRI–TβRII complex then phosphorylates Smad 2/3
  proteins, which complex with Smad4 to accumulate in the nucleus and act as transcription
  factors of target genes. In the non-Smad pathway, the TβRI–TβRII complex transmits
  its signal through other factors, such as by the Ras-extracellular signal-regulated
  kinase (Ras-ERK) pathway, TGF-β-activated kinase (TAK), c-Jun N-terminal kinase
  (JNK) and p38-MAPK pathways. Under activation, these factors translocate to the
  nucleus and regulate the expression of target genes. We observed that the upregulated
  IL-13 expression induced by TGF-β occurs via GATA-3 transcription factor modulation
  through Smad3 and p38-MAPK signaling pathways, which is reversed by the specific
  Smad3 inhibitor SIS3 or by the specific p38 inhibitor SB203580, respectively. Additionally,
  the ALK5-specific inhibition by SB431542 abolishes the TGF-β-induced Smad3 phosphorylation.
  CBP CREB-binding protein, COL1A collagen type I alpha, MCP-1 monocyte chemoattractant
  protein 1, SBE Smad-binding element, α-SMA α-smooth muscle actin
pmcid: PMC4521372
papertitle: Transforming growth factor-β increases interleukin-13 synthesis via GATA-3
  transcription factor in T-lymphocytes from patients with systemic sclerosis.
reftext: Julie Baraut, et al. Arthritis Res Ther. 2015;17(1):196.
pmc_ranked_result_index: '35273'
pathway_score: 0.9623712
filename: 13075_2015_708_Fig6_HTML.jpg
figtitle: Schematic hypothesis about interleukin (IL)-13 synthesis induced through
  Smad and mitogen-activated protein kinase (MAPK) pathways in response to transforming
  growth factor (TGF)B in T cells of patients with systemic sclerosis
year: '2015'
organisms:
- Homo sapiens
ndex: e0ea4415-ded9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4521372__13075_2015_708_Fig6_HTML.html
  '@type': Dataset
  description: Schematic hypothesis about interleukin (IL)-13 synthesis induced through
    Smad and mitogen-activated protein kinase (MAPK) pathways in response to transforming
    growth factor (TGF)-β in T cells of patients with systemic sclerosis. TGF-β binds
    first to its type II receptor (TβRII), which then recruits and phosphorylates
    the type I receptor (TβRI), leading to activin receptor-like kinase (ALK5) activation
    within the receptor complex. The TβRI–TβRII complex then phosphorylates Smad 2/3
    proteins, which complex with Smad4 to accumulate in the nucleus and act as transcription
    factors of target genes. In the non-Smad pathway, the TβRI–TβRII complex transmits
    its signal through other factors, such as by the Ras-extracellular signal-regulated
    kinase (Ras-ERK) pathway, TGF-β-activated kinase (TAK), c-Jun N-terminal kinase
    (JNK) and p38-MAPK pathways. Under activation, these factors translocate to the
    nucleus and regulate the expression of target genes. We observed that the upregulated
    IL-13 expression induced by TGF-β occurs via GATA-3 transcription factor modulation
    through Smad3 and p38-MAPK signaling pathways, which is reversed by the specific
    Smad3 inhibitor SIS3 or by the specific p38 inhibitor SB203580, respectively.
    Additionally, the ALK5-specific inhibition by SB431542 abolishes the TGF-β-induced
    Smad3 phosphorylation. CBP CREB-binding protein, COL1A collagen type I alpha,
    MCP-1 monocyte chemoattractant protein 1, SBE Smad-binding element, α-SMA α-smooth
    muscle actin
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - GATA3
  - EP300
  - MAPK3
  - IL13
  - MAPK13
  - KRAS
  - OPN1LW
  - MAPK11
  - IL6
  - MAPK8
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - SMAD4
  - CDK9
  - TGFBR1
  - MAPK10
  - SMAD6
  - MAPK14
  - S100A8
  - TGFBR2
  - HRAS
  - NRAS
  - MAPK9
  - TGFB1
  - MAP2K1
  - SMAD1
  - MAPK12
  - SMAD5
  - CCL2
  - TGFB3
  - MAP2K2
  - TGFB2
  - SB203580
  - SB431542
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: (GATA-3
  symbol: GATA3
  source: hgnc_symbol
  hgnc_symbol: GATA3
  entrez: '2625'
- word: CBP/p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: +IL-13
  symbol: IL13
  source: hgnc_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: IL-13
  symbol: IL-13
  source: hgnc_alias_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CBP/p300
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: IL-6,.
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6,.
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD7
  entrez: '4092'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: Smad2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: Smad2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TAK
  symbol: TAK
  source: hgnc_alias_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: TBRI
  symbol: TBR-i
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD6
  entrez: '4091'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: CAGA
  symbol: CAGA
  source: hgnc_prev_symbol
  hgnc_symbol: S100A8
  entrez: '6279'
- word: TBRII
  symbol: TBRII
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD1
  entrez: '4086'
- word: (ALK5)
  symbol: ALK-5
  source: hgnc_alias_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD5
  entrez: '4090'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MCP-1,.
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: MCP-1,.
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: (MAPK)
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Smad
  symbol: SMAD
  source: bioentities_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
chemicals:
- word: SB203580
  source: MESH
  identifier: C093642
- word: SB431542
  source: MESH
  identifier: C459179
diseases: []
figid_alias: PMC4521372__F6
redirect_from: /figures/PMC4521372__F6
figtype: Figure
---
